Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Hwang completed his undergraduate degree at Stanford University, and his MD and otolaryngology residency at the University of California, San Francisco. After completing a fellowship in rhinology at the University of Pennsylvania, Dr. Hwang served as Director of Rhinology at Oregon Health & Science University. He returned to Stanford in 2005 to lead the Division of Rhinology and Endoscopic Skull Base Surgery and currently serves as Vice Chair of Clinical Affairs for the Department of Otolaryngology-Head & Neck Surgery. Dr. Hwang has served in leadership of the American Rhinologic Society for over a decade, most recently as President of the society. Dr. Hwang also serves as Associate Editor of the International Forum of Allergy and Rhinology and Associate Editor of the World Journal of Otolaryngology. He co-edited the textbook "Rhinology: Diseases of the Nose, Sinuses, & Skull Base," which was awarded the Benjamin Franklin Award for Scientific & Technical Book of the Year. Dr. Hwang teaches on the latest advances in endoscopic sinus and skull base surgery at many national and international venues. He also trains future academic leaders in rhinology through the Stanford fellowship in rhinology and endoscopic skull base surgery. His research interests include clinical outcomes of endoscopic skull base surgery; development of innovative medical devices for treating sinus disease; and novel topical therapies for chronic rhinosinusitis.
- Clinical outcomes in patients with chronic rhinosinusitis undergoing endoscopic sinus surgery- Development of innovative medical devices for treatment of sinus disorders- Founder of CORSICA, a national research registry for sinus cancer
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
This randomized phase II trial studies how well chemotherapy before surgery and radiation
therapy works compared to surgery and radiation therapy alone in treating patients with nasal
and paranasal sinus cancer that can be removed by surgery. Drugs used in chemotherapy, such
as docetaxel, cisplatin, and carboplatin work in different ways to stop the growth of tumor
cells, either by killing the cells, by stopping them from dividing, or by stopping them from
spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors.
Giving chemotherapy before surgery and radiation therapy may make the tumor smaller and
reduce the amount of normal tissue that needs to be removed and treated with radiation.
View full details
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
Through this study, we hope to learn more about the mechanisms, which may contribute to
development and progression of head and neck cancer. The long-term goal of this study will be
to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.